New hope for dialysis patients: drug aims to fix anemia without injections

NCT ID NCT03461146

Completed Disease control Sponsor: Tanabe Pharma Corporation Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 06, 2026 · Updated 22 times

Summary

This study tested a pill called MT-6548 in 24 adults in Japan who have anemia due to chronic kidney disease and are on hemodialysis. The goal was to see if the drug can safely raise and maintain their hemoglobin levels within a target range. Participants were not using other anemia treatments before starting the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research site

Aichi, Japan
Research site

Chiba, Japan
Research site

Fukushima, Japan
Research site

Gunma, Japan
Research site

Hokkaido, Japan
Research site

Hyōgo, Japan
Research site

Ibaraki, Japan
Research site

Kagoshima, Japan
Research site

Nagano, Japan
Research site

Okayama, Japan
Research site

Okinawa, Japan
Research site

Osaka, Japan
Research site

Saitama, Japan
Research site

Shiga, Japan
Research site

Shizuoka, Japan
Research site

Yamagata, Japan

Conditions

Explore the condition pages connected to this study.

ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE